–News Direct– By Meg Flippin, Benzinga With the economy slowing and advances in artificial intelligence (AI) technology accelerating, reskilling is becoming an important component of any companys success. AI and its accompanying automation could render…
–News Direct– By Faith Ashmore, Benzinga Oncotelic Therapeutics (OTCQB: OTLC) is a clinical-stage biopharmaceutical company. Its primary focus is on developing innovative drugs for oncology and infectious disease and aging. OT-101 is the companys lead…
–News Direct– The world has collectively turned its attention towards nuclear energy as a saving grace for clean energy solutions, investments are continuing to pour into the space. The latest capital to hit the uranium…
–News Direct– Puerto Ricos vibrant culture and rich musical heritage came alive during the Puerto Ricos Centennial Celebration of Tito Puente, a series of events that captivated audiences throughout Hispanic Heritage Month. From September 25…
–News Direct– Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) CEO Mark Learmonth speaks to Proactive's Thomas Warner after releasing a Q3 production update for the gold producer's Blanket gold mine third quarter that puts the company…
New York City, New York Oct 11, 2023 (Issuewire.com) – Esteemed hedge fund strategist and founder of Islet Capital Management, Joseph Samuels, is proud to announce the establishment of the “Joseph Samuels Scholarship for Visual…
This Halloween is going to get more special with IssueWire’s Pre-Halloween Sale, applicable on all Press release distribution and writing services with a 10% discount. Boston, Massachusetts Oct 11, 2023 (Issuewire.com) – It is time…
–News Direct– Tematica Research Head of Indexing Mark Abssy joins Thomas Warner from Proactive to discuss the current state of the digital connectivity and infrastructure markets. Abssy highlights the general pullback in equities in September,…
–News Direct– The fund managers of Downing Fund Managers' VT Downing European Unconstrained Income Fund, Mike Clements and Pras Jeyanandhan, visit the Proactive London studio to speak with Thomas Warner about how the fund has…
–News Direct– Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive after the biotechnology company announced encouraging interim data from its phase II CALLIPER trial assessing the potential of…
© 2021 Endowment Lock. All rights reserved | Design & develop by AmpleThemes
